DE NICOLAO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 14.127
AS - Asia 8.793
EU - Europa 7.813
SA - Sud America 975
AF - Africa 252
Continente sconosciuto - Info sul continente non disponibili 208
OC - Oceania 16
AN - Antartide 1
Totale 32.185
Nazione #
US - Stati Uniti d'America 13.705
CN - Cina 4.587
SG - Singapore 1.972
IE - Irlanda 1.550
UA - Ucraina 1.133
HK - Hong Kong 879
DE - Germania 799
FI - Finlandia 755
RU - Federazione Russa 713
BR - Brasile 702
IT - Italia 617
VN - Vietnam 584
NL - Olanda 524
SE - Svezia 485
GB - Regno Unito 470
FR - Francia 464
IN - India 178
CA - Canada 174
ZA - Sudafrica 123
BD - Bangladesh 90
AR - Argentina 87
MX - Messico 80
IQ - Iraq 78
BE - Belgio 54
PL - Polonia 52
TR - Turchia 49
JP - Giappone 48
EC - Ecuador 44
CO - Colombia 42
PK - Pakistan 41
ES - Italia 36
MA - Marocco 34
JM - Giamaica 32
ID - Indonesia 30
MY - Malesia 30
UZ - Uzbekistan 29
VE - Venezuela 29
AT - Austria 27
PT - Portogallo 25
PH - Filippine 24
CL - Cile 22
SA - Arabia Saudita 22
HN - Honduras 20
AZ - Azerbaigian 18
CR - Costa Rica 18
JO - Giordania 18
PY - Paraguay 18
SV - El Salvador 18
TT - Trinidad e Tobago 16
GT - Guatemala 15
LT - Lituania 15
EU - Europa 14
PR - Porto Rico 14
TN - Tunisia 14
AU - Australia 13
IR - Iran 13
BO - Bolivia 12
CW - ???statistics.table.value.countryCode.CW??? 12
PE - Perù 12
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
EG - Egitto 11
SK - Slovacchia (Repubblica Slovacca) 11
NI - Nicaragua 10
NP - Nepal 10
CZ - Repubblica Ceca 9
KE - Kenya 9
KG - Kirghizistan 9
CH - Svizzera 8
EE - Estonia 8
ET - Etiopia 8
GP - Guadalupe 8
KR - Corea 8
TH - Thailandia 8
BH - Bahrain 7
DO - Repubblica Dominicana 7
GR - Grecia 7
KZ - Kazakistan 7
OM - Oman 7
PA - Panama 7
AL - Albania 6
BY - Bielorussia 6
KW - Kuwait 6
NG - Nigeria 6
NO - Norvegia 6
RO - Romania 6
SN - Senegal 6
LV - Lettonia 5
LY - Libia 5
PS - Palestinian Territory 5
TW - Taiwan 5
UY - Uruguay 5
IL - Israele 4
GA - Gabon 3
GE - Georgia 3
HU - Ungheria 3
IS - Islanda 3
LB - Libano 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
Totale 31.951
Città #
Chandler 1.580
Dublin 1.549
Jacksonville 1.343
San Jose 1.318
Ashburn 1.125
Nanjing 1.099
Singapore 1.010
Hong Kong 842
Council Bluffs 717
Dallas 706
Boardman 645
Beijing 641
Nanchang 423
Princeton 327
Shenyang 306
Los Angeles 302
Lawrence 297
Wilmington 290
Hebei 285
Lauterbourg 282
Changsha 266
Jiaxing 255
Ann Arbor 236
Medford 219
Ho Chi Minh City 210
Helsinki 169
Buffalo 156
Tianjin 156
Milan 154
Hangzhou 151
Hanoi 130
Moscow 129
Santa Clara 119
Woodbridge 119
Shanghai 117
New York 113
Piscataway 106
Johannesburg 97
Munich 95
Redondo Beach 88
Dearborn 81
São Paulo 73
Verona 71
Norwalk 61
Orem 61
Chicago 59
Toronto 58
Seattle 55
Rome 49
Brussels 48
Houston 48
Frankfurt am Main 46
Pavia 46
The Dalles 46
San Francisco 40
Tokyo 40
Atlanta 38
Guangzhou 38
Montreal 38
Turku 37
Warsaw 37
Des Moines 36
Kunming 34
Brooklyn 32
Falkenstein 32
Mexico City 32
London 30
Zhengzhou 30
Jinan 29
Phoenix 27
Fairfield 26
Tashkent 26
Boston 25
Denver 25
Baghdad 23
Chennai 23
Da Nang 23
Dong Ket 23
Manchester 23
Ningbo 23
Stockholm 23
Washington 23
Amsterdam 22
Newark 22
Poplar 22
Rio de Janeiro 22
Kingston 21
Columbus 20
Nuremberg 20
Salvador 20
Brasília 19
Mumbai 19
Amman 18
Las Vegas 18
Guayaquil 17
Hải Dương 17
Pune 17
Haiphong 16
Kuala Lumpur 16
Quito 16
Totale 20.152
Nome #
Steady-state equivalence of drug- and biomarker driven models in tumor growth experiments 596
Diabetes: Models, signals and control 235
Tumor-growth inhibition in preclinical animal studies: steady-state analysis of biomarker-driven models 214
First-order longitudinal population model of FEV1 data: single-trial modeling and meta-analysis 197
A Bayesian approach to non-parametric AUC estimation in population studies 193
Artificial pancreas: Model predictive control design from clinical experience 179
Biomarker-driven models of tumor growth inhibition in preclinical animal studies 167
MPC-based artificial pancreas: Strategies for individualization and meal compensation 161
Population Pharmacokinetic Model of Ibrutinib, a BTK Inhibitor for the Treatment of B-cell malignancies 160
A stabilizing model-based predictive control for nonlinear systems 159
A Target-Mediated Drug Disposition model integrated with a T lymphocyte pharmacodynamic model for Otelixizumab. 152
A Bayesian nonparametric approach to AUC determination in population studies 152
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 149
A mathematical model to study the effects of drugs administration on tumor growth dynamics 145
A PCA approach to population analysis: with application to a Phase II depression trial 143
A Target-Mediated Drug Disposition model to quantify the relationship between Otelixizumab in vitro concentration and TCR/CD3 engagement 143
PCA-based modelling in antidepressant trials: a pre-mechanistic approach 143
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time 142
A Target-Mediated Drug Disposition model to quantify the relationship between Anti-CD3 monoclonal antibody and CD3/TCR receptors in Patients with autoimmune diseases. 142
Multistep virtual metrology approaches for semiconductor manufacturing processes 141
Counting events: population approaches using NONMEM 140
Adaptive Controllers for Intelligent Monitoring 140
Integration of response, tolerability and dropout in flexible-dose trials: a case study in depression 140
Evaluation of software tools for Bayesian estimation on population models:an update based on current software versions 140
A Kalman filtering algorithm for regularization networks 139
Bayesian population approaches to the analysis of dose escalation studies 138
Predicting the active doses in humans from animal studies: A novel approach in oncology 137
Continuous-time Markov modelling of flexible-dose depression trials 137
Methods and tools for multiscale modelling in Systems Pharmacology: a review 137
Second-order indirect response modelling of complex biomarker dynamics 136
Multi-step virtual metrology for semiconductor manufacturing: A multilevel and regularization methods-based approach 135
Multilevel Lasso Applied to Virtual Metrology in Semiconductor Manufacturing 135
Model predictive control: output feedback and tracking of nonlinear systems 134
Population modeling of tumor growth in untreated xenografted mice 133
Second order Markov modelling of HAMD responses in depression trials 133
A PK-PD model for predicting tumor growth inhibition in mice: a useful tool in oncology drug development 133
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 132
Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies 132
A nonparametric approach for model individualization in an artificial pancreas 132
Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia 131
Heart rate correction of the QT interval: a nonparametric individualized approach 130
Modeling myelosuppression in patients treated with anticancer drugs 130
Identification and idle speed control of internal combustion engines 129
A hidden-Gamma model-based filtering and prediction approach for monotonic health factors in manufacturing 129
Some comments on nu-Support Vector Machines 128
ACID: Automatic classification of sort test maps for interactive process diagnosis 128
Population modeling of tumor growth inhibition in vivo: application to anticancer drug development 127
Population state-space modelling of patient responses in antidepressant studies 126
Fast calibration of two-factor models for energy option pricing 126
Process Diagnosis via Electrical-Wafer-Sorting Maps Classification 125
Particle filtering of hidden Gamma processes for robust Predictive Maintenance in semiconductor manufacturing 125
Kernel methods in system identification, machine learning and function estimation: A survey 125
H-infinity differential Riccati equations: convergence properties and finite escape phenomena 124
Nonparametric identification of population models via Gaussian processes 123
Multilevel kernel methods for virtual metrology in semiconductor manufacturing 123
An information-theory and Virtual Metrology-based approach to Run-to-Run semiconductor manufacturing control 123
Tumor growth modelling for drug development 123
PK/PD modeling of tumor growth inhibition in vivo 122
H_infinity-robustness of adaptive filters against measurement noise and parameter drift 122
Nonparametric input estimation in physiological systems: Problems, methods, case studies 122
Proportional Hazard Model with L1 Penalization applied to Predictive Maintenance in Semiconductor Manufacturing 122
MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues 122
A mininal model of tumor growth inhibition 121
Testing additivity of anticancer agents in pre-clinical studies: A PK/PD modelling approach 121
Multilevel Lasso Applied to Virtual Metrology in Semiconductor Manufacturing 121
Temporal pharmacokinetic/pharmacodynamic interaction between human CD3ε antigen-targeted monoclonal antibody otelixizumab and CD3ε binding and expression in human peripheral blood mononuclear cell static culture 121
Evaluation of software tools for Bayesian estimation on population models with count and continuous data 121
Nonparametric identification of pharmacokinetic population models via Gaussian processes 120
A new kernel-based approach for linear system identification 120
Model Predictive Control of Type 1 diabetes added to conventional therapy 120
A state-space approach to disease and dropout modelling in Phase II clinical trials 119
Disease and dropout modelling in depression trials: a state-space approach 119
A New Neural Network Approach for Short-Term Glucose Prediction Using Continuous Glucose Monitoring Time-Series and Meal Information 119
A collision risk assessment approach as a basis for the on-board warning generation in cars 119
MPC based Artificial Pancreas: Strategies for individualization and meal compensation 119
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administrations of anticancer agents 118
Multilevel statistical process control of asynchronous multi-stream processes in semiconductor manufacturing 118
Bayesian online multi-task learning of Gaussian processes 117
A new, second-order indirect model of depression time course 117
An Algebraic Characterization of the Optimum of Regularized Kernel Methods 117
A multi-task learning approach for the extraction of single-trial evoked potentials 116
Unsupervised algorithms for automatic classification of EWS maps: A comparison 115
WINSTODEC: A stochastic deconvolution program for physiological and pharmacokinetic systems 115
Method to evaluate the systemic exposure in toxicological and pharmacological studies 115
AC/ID: a Wafer Oriented Process Diagnosis Techniques 115
A new kernel-based approach for system identification 115
Nonparametric modelling of in vitro antitumor pharmacodynamic studies to optimize drug concentration and treatment time 114
On the zeros of discrete-time linear periodic systems 114
Modeling of human tumor xenografts and dose rationale in oncology 114
Output feedback and tracking of nonlinear systems with model predictive control 114
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 114
A new statistical algorithmm to enhance volume diagnostic effectiveness and accuracy 113
Dose escalation studies in Phase I clinical trials: a comparison among Bayesian population approaches 113
A model based approach to the in vitro evaluation of anticancer activity 113
A letter on Ancaiani et al. ‘Evaluating scientific research in Italy: the 2004-10 research evaluation exercise’ 113
Modelling of the outcome of non-inferiority trials by integration of historical data 112
Model predictive control of type 1 diabetes: An in silico trial 112
Current mathematical models for cancer drug discovery 112
A Novel Nonparametric Approach for the Identification of the Glucose-Insulin System in Type 1 Diabetic Patients 112
Re: Antitumor Efficacy Testing in Rodents 111
Totale 13.600
Categoria #
all - tutte 136.796
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.796


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.651 0 0 0 20 17 39 22 81 66 29 221 1.156
2022/20234.519 496 310 66 350 543 435 8 238 1.858 31 130 54
2023/20241.537 179 231 75 111 152 328 57 133 13 45 138 75
2024/20253.995 92 401 81 173 131 138 137 373 968 92 436 973
2025/20269.145 700 604 1.031 796 1.146 408 1.782 331 760 813 376 398
2026/20272.577 182 666 722 1.007 0 0 0 0 0 0 0 0
Totale 32.185